Stephan Dietrich A 4
4 · NeuBase Therapeutics, Inc. · Filed May 26, 2020
Insider Transaction Report
Form 4
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2020-05-21$8.09/sh+1,250$10,111→ 11,250 total
Holdings
- 2,547,639(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by Dietrich Stephan as a tenant by the entirety with his spouse.
- [F2]Shares held directly by Lipizzaner LLC, of which Dr. Stephan is the sole member.